经远端桡动脉与常规桡动脉行冠状动脉介入治疗老年冠心病患者的效果

摘要
图/表
参考文献(18)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨经远端桡动脉与常规桡动脉行经皮冠状动脉介入（PCI）治疗老年冠心病患者的效果。方法选取2019年2月至2021年2月江苏省扬中市人民医院收治的78 例老年冠心病患者作为研究对象，按照随机数字表法分为对照组（39 例）与研究组（39 例）。对照组采用常规桡动脉行PCI 治疗方法，研究组采用经远端桡动脉行PCI 治疗方法。比较两组患者的治疗效果、治疗前后的心功能参数左室收缩末期容积（LVESV）与左室射血分数（LVEF）及术后并发症发生情况。结果研究组的总有效率高于对照组，差异有统计学意义（P＜0.05）。治疗前，两组患者的LVESV、LVEF 水平比较，差异无统计学意义（P＞0.05）。两组患者治疗后的LVESV 水平低于治疗前，LVEF 水平高于治疗前，且研究组患者治疗后的LVESV 水平低于对照组，LVEF 水平高于对照组，差异有统计学意义（P＜0.05）。研究组患者的术后并发症总发生率低于对照组，差异有统计学意义（P＜0.05）。结论与常规桡动脉行PCI 治疗相比，经远端桡动脉行PCI 治疗年龄＞60 岁冠心病患者能够明显提高效果，有利于促进心功能恢复，减少术后并发症的发生。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	周海涛
	徐国欣
	张德新

关键词 ：冠心病, 经远端桡动脉, 常规桡动脉, 冠状动脉介入

Abstract：Objective To explore the effect of percutaneous coronary intervention (PCI) through distal radial artery and conventional radial artery in the treatment of elderly patients with coronary heart disease. Methods A total of 78 elderly patients with coronary heart disease treated in Yangzhong People′s Hospital of Jiangsu Province from February 2019 to February 2021 were selected as the research objects. They were divided into the control group (39 cases) and the study group (39 cases) according to random number table method. The control group was treated with conventional radial artery PCI, and the study group was treated with distal radial artery PCI. The treatment effect, cardiac function parameters, left ventricular end systolic volume (LVESV) and left ventricular ejection fraction (LVEF) before and after treatment, postoperative complications were compared between the two groups. Results The total effective rate of the study group was higher than that of the control group, the difference was statistically significant (P＜0.05). There were no significant differences in the levels of LVESV and LVEF between the two groups before treatment (P＞0.05). The levels of LVESV in the two groups after treatment were lower than those before treatment, and the levels of LVEF in the two groups after treatment were higher than those before treatment, and the level of LVESV in the study group after treatment was lower than that in the control group, the level of LVEF in the study group after treatment was higher than that in the control group, the differences were statistically significant (P＜0.05). The total incidence of postoperative complications in the study group was lower than that in the control group, the difference was statistically significant (P＜0.05).Conclusion Compared with conventional radial artery PCI, PCI through distal radial artery can significantly improve the curative effect of patients with coronary heart disease aged ＞60 years, promote the recovery of cardiac function and reduce the incidence of postoperative complications.

Key words： Coronary heart disease Through distal radial artery Conventional radial artery Coronary intervention

作者简介: 周海涛（1978-），男，汉族，黑龙江人，副主任医师，研究方向：心血管内科相关疾病。

引用本文:

周海涛；徐国欣；张德新. 经远端桡动脉与常规桡动脉行冠状动脉介入治疗老年冠心病患者的效果[J]. 中国当代医药, 2022, 29(16): 107-110.
ZHOU Haitao； XU Guoxin ；ZHANG Dexin. Effect of percutaneous coronary intervention through distal radial artery and conventional radial artery in the treatment of elderly patients with coronary heart disease. 中国当代医药, 2022, 29(16): 107-110.

链接本文:

https://www.dangdaiyiyao.com/CN/ 或 https://www.dangdaiyiyao.com/CN/Y2022/V29/I16/107

[1]	韩鹏，汪钦，刘浩林，等.PCI 及CABG 治疗严重病变程度冠心病患者的临床效果比较[J].现代生物医学进展，2019，19（23）：4445-4449.
[2]	钱海燕，黄觊，马文健，等.冠状动脉血流储备分数位于灰区的老年冠心病患者不同治疗策略[J].中华老年医学杂志，2020，39（3）：273-276.
[3]	赵帅，王伟，汪钦，等.PCI 治疗对CTO 合并LVEF 降低的冠心病患者术后短期生活质量的影响[J].中国动脉硬化杂志，2019，27（7）：593-598.
[4]	吴尘乐.老年冠心病病人PCI 术中应用比伐卢定治疗的临床研究[J].中西医结合心脑血管病杂志，2019，17（12）：1855-1857.
[5]	邵利辉，王艳娟，李敏，等.PCI 术后早期康复对冠心病患者心脏康复的作用研究[J].心血管康复医学杂志，2019，28（5）：571-575.
[6]	De Bruyne B，Pijls NHJ，Kalesan B，et al.Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J].N Engl J Med，2012，367（11）：991-1001.
[7]	Zhang H，Chang R.Effects of exercise after percutaneous coronary intervention on cardiac function and cardiovascular adverse events in patients with coronary heart disease：systematic review and Meta-analysis[J].J Sports Sci Med，2019，18（2）：213-222.
[8]	国家卫生计生委合理用药专家委员会，中国药师协会.冠心病合理用药指南（第2 版）[J].中国医学前沿杂志（电子版），2018，10（6）：1-130.
[9]	吴国顺.N 末端B 型钠尿肽原与美国纽约心脏病学会心功能分级在心力衰竭诊断中的相关性对比分析[J].中国医药指南，2014，12（23）：250-251.
[10]	Dorje T，Zhao G，Scheer A，et al.SMARTphone and social media-based Cardiac Rehabilitation and Secondary Prevention （SMART-CR/SP） for patients with coronary heart disease in China：a randomised controlled trial protocol[J].BMJ Open，2018，8（6）：e021908.
[11]	Xia TL，Huang FY，Peng Y，et al.Efficacy of Different Types of Exercise-Based Cardiac Rehabilitation on Coronary Heart Disease：a Network Meta-analysis[J].J Gen Intern Med，2018，33（12）：2201-2209.
[12]	Figulla HR，Lauten A，Maier LS，et al.Percutaneous Coronary Intervention in Stable Coronary Heart Disease-Is Less More?[J].Dtsch Arztebl Int，2020，117（9）：137-144.
[13]	Xaplanteris P，Fournier S，Pijls NHJ，et al.Five-Year Outcomes with PCI Guided by Fractional Flow Reserve[J].N Engl J Med，2018，379（3）：250-259.
[14]	Jian W，Li L，Wei XM，et al.Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI[J].Medicine （Baltimore），2019，98（5）：e14216.
[15]	Wang YX，Wang XL，Wang JR，et al.Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease：study protocol for a double-blind，randomized controlled trial[J].Trials，2020，21（1）：287.
[16]	Iqbal J，Serruys PW.Revascularization strategies for patients with stable coronary artery disease[J].J Intern Med，2014，276（4）：336-351.
[17]	Kang Q，Li XL，Yang MY，et al.Galectin-3 in patients with coronary heart disease and atrial fibrillation[J].Clin Chim Acta，2018，478：166-170.
[18]	JCS Joint Working Group.Guidelines for diagnosis and treatment of patients with vasospastic angina （Coronary Spastic Angina）（JCS 2013）[J].Circ J，2014，78（11）：2779-2801.